D.M. KRASILNIKOV¹, A.V. ZAKHAROVA¹, D.M. MIRGASIMOVA¹, R.I. NIGMATZYANOV²

¹Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation 420012

²Republican clinical hospital of the Ministry of Health of the Republic of Tatarstan, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064 

Krasilnikov D.M. — D. Med. Sc., Professor, Head of the Department of Surgical Pathologies № 1, tel. +7-987-290-27-12, e-mail: dmkras131@gmail.com¹

Zakharova A.V. — Assistant of the Department of Surgical Pathologies № 1, tel. +7-927-408-22-07, e-mail: zahanna.83@rambler.ru¹

Mirgasimova D.M. — Cand. Med. Sc., Associate Professor of the Department of Surgical Pathologies № 1, tel. +7-904-667-45-51, e-mail: d.mirgasimova@yandex.ru¹

Nigmatzyanov R.I. — operating surgeon, Head of the Department of organization of paid medical services, tel. +7-987-296-98-69, e-mail: Nigraf81@mail.ru²

There was analyzed the experience of diagnosis and treatment of 909 patients with obstructive jaundice. Obstructive jaundice of benign genesis was observed in 763 (83,9%) patients, and malignant — in 146 (16,1%) of cases. The choice of surgical treatment depended on the cause of obstructive jaundice and severity of the patient: in 414 (45,5%) cases endoscopic papillosphincterotomy was the final stage of treatment, two-stage therapeutic approach was carried out in 261 (28,7%) cases, 116 (12,8%) patients were made cholecysto-, choledocho- or hepaticostomy by percutaneous transhepatic access, 118 (13%0 patients for emergency indications were performed traditional surgical treatment The efficacy of the drug Remaxol application in the complex pre- and postoperative treatment of patients with obstructive jaundice was studied.

Key words: obstructive jaundice, diagnostics, surgical treatment, infusion hepatoprotector.

REFERENCES

1. Gal’perin E.I. et al. Lektsii po gepatopankreatobiliarnoy khirurgii: s prilozheniem CD-ROM “Lektsii po gepatopankreatobiliarnoy khirurgii” [Lectures on hepatopancreatobiliary surgery: the application CD-ROM “Lectures on hepatopancreatobiliary surgery”]. Moscow: Vidar-M, 2011. 536 p.

2. Brown K.T., Covey A.M. Management of malignant biliary obstruction. Techn. Vasc. Intervent. Radiol., 2008, vol. 11 (1), pp. 43-50.

3. D.L. Clarke et al. Management of the patient with obstructive jaundice. Ann. R. Coll. Surg. Engl., 2006, vol. 88, pp. 610-616.

4. P’yankova O.B., Busyrev Yu.B., Karpunina T.I. Clinical and epidemiological characteristics of patients with the syndrome of obstructive jaundice of benign origin. Meditsinskiy al’manakh, 2009, no. 2, pp. 173-176 (in Russ.).

5. Zyubina E.N. Khirurgicheskoe lechenie dobrokachestvennoy neprokhodimosti zhelchnykh protokov: avtoref. dis. … d-ra med. nauk [Surgical treatment of benign bile duct obstruction. Synopsis of Dis. Dr med. sci.]. Volgograd, 2008. 324 p.

6. Intensivnaya terapiya: natsional’noe rukovodstvo, pod red. Gel’fand B.R., Saltanova A.I. [Intensive care: national guidelines. Ed. B.R. Gelfand, A.I. Saltanova]. Moscow: GEOTAR-Media, 2009. Vol. 1. 269 p.

7. Maystrenko N.A., Romashchenko P.N., Strukov E.Yu. Sindrom mekhanicheskoy zheltukhi dobrokachestvennogo geneza: optimizatsiya diagnosticheskikh i lechebnykh podkhodov [Jaundice syndrome of benign origin: optimizing diagnostic and therapeutic approaches]. Aktual’nye problemy khirurgicheskoy gepatologii: Materialy 20 Mezhdunarodnogo kongressa Assotsiatsii khirurgov-gepatologov stran SNG. Donetsk, 2013. P. 118.

8. Parkhisenko Yu.A. et al. Mechanical jaundice: modern approaches to the problem of diagnosis and surgical treatment. Ukrainskiy zhurnal khirurgii, 2013, no. 3, pp. 202-214 (in Russ.).

9. Piecuch J. et. al. Analysis of causes of mechanical jaundice and treatment methods in a group of 103 hospitalized patients. Wiad Lek., 2003, vol. 56 (3-4), pp. 157-161.

10. Turkcapar N., Bayar S., Koyuncu A. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice. Hepatogastroenterology, 2003, vol. 50 (51), pp. 680-683.

11. Savel’ev B.C. 80 lektsiy po khirurgii [80 lectures on surgery]. Moscow: Litterra, 2008. 910 p.

12. Sologub T.V., Goryacheva L.G. Hepatoprotective activity remaksola chronic liver damage. Klinicheskaya meditsina, 2010, no. 1, pp. 62-66 (in Russ.).

13. Yakovlev A.Yu., Semenov V.B. Infusion therapy in patients with cholelithiasis complicated by obstructive jaundice. Khirurgiya im. N.I. Pirogova, 2010, no. 12, pp. 82-86 (in Russ.).